Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Saga Q1 2026 Earnings Negative EPS and Stock Decline Amidst Industry Headwinds OCCIN Q1 2026 Earnings Preferred Stock Reports Steep EPS Miss as Net Investment Income Falls Short XMTR Q1 2026 Earnings EPS Beat Drives Mild Stock Uptick GOODN Q1 2026 Earnings Preferred Stock Reports Strong EPS Surprise HOUR Q4 2024 Earnings Loss Per Share of 004 Reported Amid Quiet Trading